A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2002

Conditions
Hepatitis B
Interventions
DRUG

clevudine (drug)

Trial Locations (11)

19107

Thomas Jefferson University Hospital, Jefferson Medical College, Philadelphia

54511

Hospital de Brabois Chu de Nancy, Service d'Hepato-gastroenterologie, Vandœuvre-lès-Nancy

60612

University of Illinois at Chicago, Chicago

69288

Hospital Dieu, Service Hepatogastroenterologie-endoscopie, Lyon

75010

Hospital St Louis, Service de Medecine Interne, Paris

92118

Hospital Beaujon, Service Hepatologie Centre Pierre Abrami, Clichy

119074

National University Hospital, Division of Gastroenterology, Department of Medicine, Singapore

V6Z1Y8

Viridae, Vancouver

V6Z2C7

University of British Columbia, Downtown Infectious Disease Clinic, Vancouver

Unknown

Prince of Wales Hospital, Department of Medicine and Therapeutics, Hong Kong

The University of Hong Kong, Clinical Trials Centre, Faculty of Medicine, Queen Mary Hospital, Hong Kong

Sponsors
All Listed Sponsors
lead

Triangle Pharmaceuticals

INDUSTRY